P, I., N, P., S, J., P, U., J, O., & B, S. (2023). Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report. Vaccines, 11(3), . https://doi.org/10.3390/vaccines11030537
Chicago Style (17th ed.) CitationP, Intapiboon, Pinpathomrat N, Juthong S, Uea-Areewongsa P, Ongarj J, and Siripaitoon B. "Humoral Immunogenicity of MRNA Booster Vaccination After Heterologous CoronaVac-ChAdOx1 NCoV-19 or Homologous ChAdOx1 NCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report." Vaccines 11, no. 3 (2023). https://doi.org/10.3390/vaccines11030537.
MLA (9th ed.) CitationP, Intapiboon, et al. "Humoral Immunogenicity of MRNA Booster Vaccination After Heterologous CoronaVac-ChAdOx1 NCoV-19 or Homologous ChAdOx1 NCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report." Vaccines, vol. 11, no. 3, 2023, https://doi.org/10.3390/vaccines11030537.